Skip to main content
OpenTrials
Completed

NCT Number: NCT00688675

Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

Document how Swiss GPs allocate their GERD patients to the three GERD patient segments (according to King et al.) and how treated GERD patients are affected by their GERD treatment

Completed

Looking for future studies?

Notify Me

Key information

Age range

12 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Research Site

Aarau, Switzerland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Previously diagnosed GERD patients
  • on treatment for at least 2 weeks

Exclusion criteria

  • none

Treatment and study plan

Primary outcomes

  1. % patients per GERD patient segment

    Time frame: single visit

Secondary outcomes

  1. Symptom load

    Time frame: single visit

  2. Quality of life

    Time frame: single visit

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

GERD Segmentation: Document How Swiss GPs Allocate Their GERD Patients to the Three GERD Patient Segments

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Jun 3, 2008
Registry last updated
Dec 7, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.